CP-225917 is isolated from unidentified fungi, which exhibited farnesyl transferase and squalene synthase inhibitory activity. In the present investigation, computational studies including, docking, molecular dynamic simulations, protein ligand interaction fingerprints (PLIF) analysis and pharmacokinetic properties calculations were performed on the molecule. The crystallographic structure (pdb id 3E37) was used for the docking and MD simulation studies and it provided the docking score of -11.3 and FTase inhibitory activity of IC₅₀ = 6000 nM. Further the conformational analysis studied on different conformations obtained from the MD simulations and PLIF analysis showed that the compounds has significant interaction with Lys164, Tyr166, His201, ArgB202, HisB248, TyrB300, LysB356, TyrB361, HisB362 and ZnC1001 residues in the chain A and B of the protein. However, the MD simulations revealed that the molecules has major interactions with the residues in the B chain of the FTase enzyme. The tyrosine residues (TyrB300 and TyrB361) are forming surface and side-chain acceptor interactions and the residue (TyrB361) has interaction fingerprint on the backbone acceptor and donor interactions. The histidine residues exhibited hydrogen bonding interaction and LysB356 has ionic interactions. The Zn metal showed ionic interaction with the ligand molecules for the activity. The Molecular Dynamics simulations of the complexes showed significant RMSD and RMSF values within the limit revealed that the complex is stabilized with the residues. These computational studies and the reported biological activities of the compounds showed that this compound may be used as lead compounds to develop novel FTase inhibitors.